Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Miller and colleagues, representing 29 study centers in the United States, reported the results of a Phase 2 clinical trial, assessing the impact of denosumab on bone density.

Denosumab: A New Treatment for Osteoporosis